Indonesia

Indonesia

We began working in Indonesia in 1980 with a focus on improving child health, decentralizing health services, expanding access to care and treatment for TB, and strengthening pharmaceutical management.

Overview

In partnership with the Government of Indonesia, we assist in increasing national immunization rates and improving the management and distribution of essential drugs, vaccines, contraceptives, and other health commodities. To address the high burden of TB, our programs help improve the quality of TB case detection, diagnosis, care, and prevention services at public and private health facilities; ensure reliable supply and distribution of TB medicines; and assist the Ministry of Health’s National TB Program to develop ways to increase domestic financing for Indonesia’s TB control initiatives.

  1. Resources
  2. News & Stories

Lessons Learned from Best Practices in Psycho-Socio-Economic Support for Tuberculosis Patients

Tuberculosis (TB) patients face many psychological, social and economic problems that complicate treatment and care. This may lead to decreasing adherence to prescribed treatment regimens and poorer clinical outcomes, including higher loss-to-follow-up, relapse and mortality rates.

MSH conducted research with KNCV under USAID’s TB CARE I project to identify lessons learned and best practices. The results from Indonesia and 12 other countries indicate that psycho-socio-economic support interventions can add significant value to TB control through improvements in treatment success rates and reductions in patient suffering.

Management Sciences for Health Partners with USAID to Accelerate Elimination of TB in Indonesia

MSH announced a new partnership with USAID and the Government of Indonesia to assist Indonesia in addressing the tuberculosis (TB) epidemic and achieving 2030 TB elimination targets.